|
BET inhibitor review mentioning RVX-208 and ZEN-3694
|
1
|
Resverlogix Corp.
|
Feb 03, 2019 05:44PM
|
|
Re: AHA late breaking abstract
|
1
|
Resverlogix Corp.
|
Nov 10, 2019 02:07PM
|
|
Re: biOasis Announces the Issuance of a Key US Patent
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 16, 2015 01:54PM
|
|
Re: Licensing Deal - Very Little Detail - Astellas Research
|
1
|
BIOASIS TECHNOLOGIES INC
|
Apr 21, 2016 09:20PM
|
|
Re: What Jardiance/EMPA-REG Outcome means for RVX-208
|
1
|
Resverlogix Corp.
|
Sep 17, 2015 03:36PM
|
|
Re: Finally got around to this. UN-official, of course
|
1
|
Resverlogix Corp.
|
Sep 17, 2015 03:37PM
|
|
Re: Resverlogix To Host Epigenetics Focused Symposium At The ERA-EDTA Congress in Madrid, Spain
|
1
|
Resverlogix Corp.
|
May 31, 2017 09:52AM
|
|
Re: DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
1
|
Resverlogix Corp.
|
Mar 28, 2019 08:14PM
|
|
Re: MD&A... Phase 3...Questions for BDZ....
|
1
|
Resverlogix Corp.
|
Sep 05, 2015 12:31PM
|
|
Re: AMRN / Adcom
|
1
|
Resverlogix Corp.
|
Aug 10, 2019 03:45PM
|
|
Re: EDITRe: i would love to hear,..
|
1
|
Resverlogix Corp.
|
Dec 06, 2019 11:25AM
|
|
Resverlogix & EVERSANA Announce Partnership to Support the Pending Launch of the Initial Commercialization of Apabetalone for COVID-19 in US & Canada
|
1
|
Resverlogix Corp.
|
Jun 03, 2021 10:38AM
|
|
Q1 events list updated
|
1
|
Resverlogix Corp.
|
Jan 11, 2017 10:37AM
|
|
Angiochem receives $7.5 million in Series C financing
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 02, 2018 09:17AM
|
|
Resverlogix Provides Groundbreaking Results in Patients with Severe Kidney Impairments
|
1
|
Resverlogix Corp.
|
Jan 23, 2017 11:17AM
|
|
BIO Investor Forum
|
1
|
Zenith Epigenetics
|
Oct 01, 2017 08:01AM
|
|
Re: Key Players
|
1
|
Resverlogix Corp.
|
Aug 31, 2016 10:51PM
|
|
Re: Gran Oso.....
|
1
|
Resverlogix Corp.
|
Nov 01, 2019 10:06AM
|
|
Re: An invitation to join the conversation here on Agoracom
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jun 21, 2018 02:34PM
|
|
Re: NR
|
1
|
Resverlogix Corp.
|
Jan 23, 2017 11:19AM
|
